Unified Women's Healthcare, a health-management company focused solely on women, announced its acquisition of Gennev, a digital menopause care-delivery platform. The financial terms of the deal were not disclosed. 

Seattle-based Gennev, previously known as Genneve, provides menopause patients personalized treatment through its network of OB-GYNs, health coaches and registered dietitians.

The Florida-based company will add Gennev to its portfolio of women-focused businesses, including Women's Health USA, a practice-management services company for the women's sector; CCRM Fertility, a fertility treatment and science company; the Femmina Group, a company offering over-the-counter products for women undergoing hormonal changes; and Lucina, a maternity analytics platform aimed at improving birth outcomes.

"The Gennev platform will expand Unified's goal to deliver better outcomes and an enhanced patient experience throughout all moments and milestones in a woman's healthcare journey," Bob LaGalia, Unified Women's Healthcare president and CEO, said in a statement. 

"This strategic investment in Gennev will allow Unified to provide essential care to women nationwide, and complement the services now delivered by our 2,500 affiliated women's healthcare providers across 900 locations throughout the United States."

THE LARGER TREND

Though there are fewer menopause care companies compared with startups focused on reproductive-age issues, a 2021 report by consulting and research firm Frost & Sullivan argued shifting to untapped market areas will be a key factor to the femtech sector’s growth.

Menopause-focused telehealth startup Evernow, which matches users to a clinician who helps build a personalized treatment plan based on the patient's health history, garnered $28.5 million in Series A funding in April. 

In February, menopause startup Bia Care, a company connecting women to menopause specialists through group consultations, announced its expanded partnership with the NHS to deliver a digitally-enabled women's health clinic.